Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors

被引：47

作者：

Cheng, Ming-Fu ^{[1
]}

Hung, Ming-Shiu ^{[1
]}

Song, Jen-Shin ^{[1
]}

Lin, Shu-Yu ^{[1
]}

Liao, Fang-Yu ^{[1
]}

Wu, Mine-Hsine ^{[1
]}

Hsiao, Wenchi ^{[1
]}

Hsieh, Chia-Ling ^{[1
]}

Wu, Jian-Sung ^{[1
]}

Chao, Yu-Sheng ^{[1
]}

Shih, Chuan ^{[1
]}

Wu, Su-Ying ^{[1
]}

Ueng, Shau-Hua ^{[1
]}

机构：

[1] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan 35053, Miaoli County, Taiwan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2014年 / 24卷 / 15期

关键词：

Sulfonylhydrazide; Indoleamine 2,3-dioxygenase; Structure-activity relationship; Molecular docking; CANCER-IMMUNOTHERAPY; DERIVATIVES; INDOLEAMINE-2,3-DIOXYGENASE; BLOCKADE; TARGET; PD-1;

D O I：

10.1016/j.bmcl.2014.05.084

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel class of phenyl benzenesulfonylhydrazides has been identified as potent inhibitors of indoleamine 2,3-dioxygenase (IDO), and their structure-activity relationship was explored. Coupling reactions between various benzenesulfonyl chlorides and phenylhydrazides were utilized to synthesize the sulfonylhydrazides bearing various substituents. Compound 3i exhibited 61 nM of IC50 in enzymatic assay and 172 nM of EC50 in the HeLa cell. The computational study of 3i suggested that the major interactions between 3i and IDO protein are the coordination of sulfone and heme iron, the hydrogen bonding and hydrophobic interactions between 3i and IDO. This novel class of IDO inhibitor provides a new direction to discover effective anti-cancer agents. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：3403 / 3406

页数：4

共 50 条

[41] What May Constrain the Success of Indoleamine 2,3-Dioxygenase 1 Inhibitors in Cancer Immunotherapy?
Eleftheriadis, Theodoros
[J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
[42] Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
Roehrig, Ute F.
Majjigapu, Somi Reddy
Vogel, Pierre
Reynaud, Aline
Pojer, Florence
Dilek, Nahzli
Reichenbach, Patrick
Ascencao, Kelly
Irving, Melita
Coukos, George
Michielin, Olivier
Zoete, Vincent
[J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 1773 - 1811
[43] Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO)
Zhang, Shengnan
Guo, Leilei
Yang, Dan
Xing, Zikang
Li, Weirui
Kuang, Chunxiang
Yang, Qing
[J]. BIOORGANIC CHEMISTRY, 2020, 104
[44] Structure-activity relationship studies of 5-(Pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 inhibitors
Zhang, Jiawei
Liu, Jingyi
Kong, Kaimin
Li, Xingzhou
Zhang, Qian
[J]. RESULTS IN CHEMISTRY, 2024, 7
[45] Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen
Smith, Jason R.
Evans, Krystal J.
Wright, Adam
Willows, Robert D.
Jamie, Joanne F.
Griffith, Renate
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (03) : 1354 - 1363
[46] Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Selvan, Senthamil R.
Dowling, John P.
Kelly, William K.
Lin, Jianqing
[J]. CURRENT CANCER DRUG TARGETS, 2016, 16 (09) : 755 - 764
[47] Inhibitory Substrate Binding Site of Human Indoleamine 2,3-Dioxygenase
Lu, Changyuan
Lin, Yu
Yeh, Syun-Ru
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (36) : 12866 - +
[48] Nanomolar potency of imidazo[2,1-b]thiazole analogs as indoleamine 2,3-dioxygenase inhibitors
Ewida, Menna A.
Ewida, Heba A.
Ahmed, Mahmoud S.
Allam, Heba Abdelrasheed
ElBagary, Ramzia, I
George, Riham F.
Georgey, Hanan H.
El-Subbagh, Hussein, I
[J]. ARCHIV DER PHARMAZIE, 2021, 354 (11)
[49] Identification of Substituted 1H-Indazoles as Potent Inhibitors for Immunosuppressive Enzyme Indoleamine 2,3-Dioxygenase 1
Pradhan, Nirmalya
Paul, Saurav
Deka, Suman Jyoti
Roy, Ashalata
Trivedi, Vishal
Manna, Debasis
[J]. CHEMISTRYSELECT, 2017, 2 (20): : 5511 - 5517
[50] Synthesis and Molecular Modeling Studies of N′-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
Lee, Dong-Ho
Lee, Joo-Youn
Jeong, Jieun
Kim, Miok
Lee, Kyung Won
Jang, Eunseo
Ahn, Sunjoo
Lee, Chang Hoon
Hwang, Jong Yeon
[J]. MOLECULES, 2017, 22 (11):

← 1 2 3 4 5 →